Peritoneal dialysis versus hemodialysis: Risks, benefits, and access issues

Ramapriya Sinnakirouchenan, Jean Lake Holley

Research output: Contribution to journalReview article

Abstract

Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible. The selection of PD or HD will usually be based on patient motivation, desire, geographic distance from an HD unit, physician and/or nurse bias, and patient education. Unfortunately, many patients are not educated on PD before beginning dialysis. Most studies show that the relative risk of death in patients on in-center HD versus PD changes over time with a lower risk on PD, especially in the first 3 months of dialysis. The survival advantage of PD continues for 1.5-2 years but, over time, the risk of death with PD equals or becomes greater than with in-center HD, depending on patient factors. Thus, PD survival is best at the start of dialysis. Patient satisfaction may be higher with PD, and PD costs are significantly lower than HD costs. The new reimbursement system, including bundling of dialysis services, may lead to an increase in the number of incident patients on PD. The high technique failure of PD persists, despite significant reductions in peritonitis rates. Infection also continues to be an important cause of mortality and morbidity among HD patients, especially those using a central venous catheter as HD access. Nephrologists' efforts should be focused on educating themselves and their patients about the opportunities for home modality therapies and reducing the reliance on central venous catheter for long-term HD access.

Original languageEnglish (US)
Pages (from-to)428-432
Number of pages5
JournalAdvances in Chronic Kidney Disease
Volume18
Issue number6
DOIs
StatePublished - Nov 1 2011

Fingerprint

Peritoneal Dialysis
Renal Dialysis
Dialysis
Central Venous Catheters
Costs and Cost Analysis
Survival
Patient Education
Peritonitis
Patient Satisfaction
Kidney Transplantation
Chronic Kidney Failure
Nurses
Morbidity
Physicians

Keywords

  • Chronic kidney disease
  • End-stage renal disease
  • Tunneled catheters

ASJC Scopus subject areas

  • Nephrology

Cite this

Peritoneal dialysis versus hemodialysis : Risks, benefits, and access issues. / Sinnakirouchenan, Ramapriya; Holley, Jean Lake.

In: Advances in Chronic Kidney Disease, Vol. 18, No. 6, 01.11.2011, p. 428-432.

Research output: Contribution to journalReview article

Sinnakirouchenan, Ramapriya ; Holley, Jean Lake. / Peritoneal dialysis versus hemodialysis : Risks, benefits, and access issues. In: Advances in Chronic Kidney Disease. 2011 ; Vol. 18, No. 6. pp. 428-432.
@article{6662e29576174bdaac58fa992a89e2ed,
title = "Peritoneal dialysis versus hemodialysis: Risks, benefits, and access issues",
abstract = "Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible. The selection of PD or HD will usually be based on patient motivation, desire, geographic distance from an HD unit, physician and/or nurse bias, and patient education. Unfortunately, many patients are not educated on PD before beginning dialysis. Most studies show that the relative risk of death in patients on in-center HD versus PD changes over time with a lower risk on PD, especially in the first 3 months of dialysis. The survival advantage of PD continues for 1.5-2 years but, over time, the risk of death with PD equals or becomes greater than with in-center HD, depending on patient factors. Thus, PD survival is best at the start of dialysis. Patient satisfaction may be higher with PD, and PD costs are significantly lower than HD costs. The new reimbursement system, including bundling of dialysis services, may lead to an increase in the number of incident patients on PD. The high technique failure of PD persists, despite significant reductions in peritonitis rates. Infection also continues to be an important cause of mortality and morbidity among HD patients, especially those using a central venous catheter as HD access. Nephrologists' efforts should be focused on educating themselves and their patients about the opportunities for home modality therapies and reducing the reliance on central venous catheter for long-term HD access.",
keywords = "Chronic kidney disease, End-stage renal disease, Tunneled catheters",
author = "Ramapriya Sinnakirouchenan and Holley, {Jean Lake}",
year = "2011",
month = "11",
day = "1",
doi = "10.1053/j.ackd.2011.09.001",
language = "English (US)",
volume = "18",
pages = "428--432",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Peritoneal dialysis versus hemodialysis

T2 - Risks, benefits, and access issues

AU - Sinnakirouchenan, Ramapriya

AU - Holley, Jean Lake

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible. The selection of PD or HD will usually be based on patient motivation, desire, geographic distance from an HD unit, physician and/or nurse bias, and patient education. Unfortunately, many patients are not educated on PD before beginning dialysis. Most studies show that the relative risk of death in patients on in-center HD versus PD changes over time with a lower risk on PD, especially in the first 3 months of dialysis. The survival advantage of PD continues for 1.5-2 years but, over time, the risk of death with PD equals or becomes greater than with in-center HD, depending on patient factors. Thus, PD survival is best at the start of dialysis. Patient satisfaction may be higher with PD, and PD costs are significantly lower than HD costs. The new reimbursement system, including bundling of dialysis services, may lead to an increase in the number of incident patients on PD. The high technique failure of PD persists, despite significant reductions in peritonitis rates. Infection also continues to be an important cause of mortality and morbidity among HD patients, especially those using a central venous catheter as HD access. Nephrologists' efforts should be focused on educating themselves and their patients about the opportunities for home modality therapies and reducing the reliance on central venous catheter for long-term HD access.

AB - Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible. The selection of PD or HD will usually be based on patient motivation, desire, geographic distance from an HD unit, physician and/or nurse bias, and patient education. Unfortunately, many patients are not educated on PD before beginning dialysis. Most studies show that the relative risk of death in patients on in-center HD versus PD changes over time with a lower risk on PD, especially in the first 3 months of dialysis. The survival advantage of PD continues for 1.5-2 years but, over time, the risk of death with PD equals or becomes greater than with in-center HD, depending on patient factors. Thus, PD survival is best at the start of dialysis. Patient satisfaction may be higher with PD, and PD costs are significantly lower than HD costs. The new reimbursement system, including bundling of dialysis services, may lead to an increase in the number of incident patients on PD. The high technique failure of PD persists, despite significant reductions in peritonitis rates. Infection also continues to be an important cause of mortality and morbidity among HD patients, especially those using a central venous catheter as HD access. Nephrologists' efforts should be focused on educating themselves and their patients about the opportunities for home modality therapies and reducing the reliance on central venous catheter for long-term HD access.

KW - Chronic kidney disease

KW - End-stage renal disease

KW - Tunneled catheters

UR - http://www.scopus.com/inward/record.url?scp=81255197611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255197611&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2011.09.001

DO - 10.1053/j.ackd.2011.09.001

M3 - Review article

C2 - 22098661

AN - SCOPUS:81255197611

VL - 18

SP - 428

EP - 432

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 6

ER -